Biogen Pharmachem Industries Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

65.26

65.26

65.26

65.26

65.26

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-10.67

-11.13

-11.12

-9.51

-10.99

Loan funds

Secured loans

-

-

-

0.31

0.63

Unsecured loans

-

-

-

-

-

Total

54.59

54.13

54.14

56.05

54.90

Uses of funds

Fixed assets

Gross block

-

-

-

-

-

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

-

-

-

-

Net block

-

-

-

-

-

Capital work-in-progress

-

-

-

-

-

Investments

8.85

6.95

9.49

6.45

4.65

Net current assets

Current assets, loans & advances

45.97

48.00

44.76

49.64

52.99

Less : current liabilities & provisions

0.24

0.82

0.11

0.04

2.73

Total net current assets

45.74

47.18

44.65

49.60

50.26

Miscellaneous expenses not written

-

-

-

-

-

Total

54.59

54.13

54.14

56.05

54.90

Notes:

Book value of unquoted investments

0.59

6.95

9.49

6.45

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

6526.03

6526.03

6526.03

6526.03

6526.03